Excipient Functionality

Moreton,R. Christian;

Excipient Functionality

May 2, 2004

By R. Christian Moreton

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-05-02-2004

Volume 28

Issue 5

The author suggests that an excipient's functionality can only be determined in the context of a specific formulation and manufacturing process.

External Link - article-94554.pdf

Articles in this issue

Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology

An LC Method for the Separation and Determination of Ethynodiol Diacetate and Ethinyl Estradiol in Tablets

In The Spotlight-May 2004

FDA Eyes Manufacturing Innovation to Boost Drug Development

Prepare for Bar Coding

Validation and Compliance: Software Systems Prepare Manufacturers for Com(PAT)ibility

aaiPharma Situation Underscores The Need for Due Diligence

Excipient Functionality

Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology

May 2004

Related Content

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney

June 30th 2025

Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

3D Rendering of CAR - Chimeric Antigen Receptor Between T-Cell and Cancer Cell | Image Credit: © Alpha Tauri 3D - stock.adobe.com

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

Patrick Lavery

June 26th 2025

Article

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024

Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.